Trial Profile
Multicentre, Controlled, Randomised, Open, Cross-over Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tbl. 500 mg in Children With Crohn´s Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Jun 2014
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms PENT-IBD-CH CZ
- Sponsors Ferring Pharmaceuticals
- 20 Jun 2014 New trial record